Mixed connective tissue disease: fact or fiction?

Citera G. , Espada G. , Maldonado Cocco JA. Sequential development of two connective tissue diseases in juvenile patients . J Rheumatol 1993; 20: 214-252.

Dubois EL , Wallace DJ Differential diagnosis. In: Wallace DJ , Dubois EL (eds). Dubois' Lupus Erythematosus . Lea & Febiger: Philadelphia , 1987, pp 470-483.

Sharp GC et al. Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Am J Med 1972; 52: 148-159.

Hench P. , Edginton TS , Tan EM The evolving clinical spectrum of mixed connective tissue disease (MCTD). Arthritis Rheum 1975; 18: 404 (abstract).

Bennet R. , O'Connell D. Mixed connective tissue disease. A clinicopathological study of 20 cases. Semin Arthritis Rheum 1980; 10: 25-52.

Leibforth JH , Perselin RH Characteristics of patients with serum antibodies to extractable nuclear antigens. Arthritis Rheum 1976; 19: 851-865.

Kitridou RC et al. Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum 1986; 16: 135-145.

Singsen BH et al. Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 1977; 90: 893-900.

Pirainen HI Patients with arthritis and anti-U1-RNP antibodies: a 10-year follow-up . Br J Rheumatol 1990; 29: 345-383.

Sullivan WD et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984; 63: 92-107.

Bennet RM , Bong DM , Spargo JH Neuropsychiatric problems in mixed connective tissue disease. Am J Med 1978; 65: 955-962.

Nietsche A. et al. Neurological features in overlap syndrome . Clin Rheumatol 1991; 10: 5-9.

Grant KD , Adams LE , Hess EV Mixed connective tissue disease. A subset with sequential clinical and laboratory features. J Rheumatol 1981; 8: 587-598.

Alarcón Segovia D. Mixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment. J Rheumatol 1979; 6: 694-699.

Sharp GC Mixed connective tissue disease. Bull Rheum Dis 1975; 25: 828-831.

Houtman PM et al. Fluctuation in anti-RNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response. Ann Rheum Dis 1986; 45: 800-808.

Nimelstein SH et al. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 1980; 59: 239-248.

Le Roy CA , Maricq HR , Kahaleh B. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341-334.

Black C. , Isenberg DA Mixed connective tissue disease. Goodbye to all that. Br J Rheumatol 1992; 31: 695-700.

Sharp GC , Singsen BH Mixed connective tissue disease. In: MacCarty DJ , Koopman WJ (eds). Arthritis and Allied Conditions. Lea & Febiger : Philadelphia, 1993, pp 1312-1224.

Bennet RM Mixed connective tissue disease and other overlap syndromes. In: Kelley WN et al (eds). Textbook of Rheumatology . WB Saunders: Philadelphia, 1993, pp 1057-1076.

Ginsburg WW et al. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients. J Rheumatol 1983; 10: 235-241.

Lázaro MA et al. Clinical and serologic characteristics of patients with overlap syndrome: is MCTD a distinct clinical entity? Medicine 1989; 68: 58-65.

Babini SM et al. Peritendinous nodules in overlap syndrome. J Rheumatol 1985; 12: 160-164.

González Paredes J et al. Jaccoud arthroplasty in hands in the overlap syndrome. Rev Esp Reumatol 1993; 20 (Suppl.) 539.

Lázaro MA et al. Pulmonary hypertension in overlap syndrome. Arthritis Rheum 1993; 36 (Suppl.) 266.

Petterson I. et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1986; 29: 986-996.

McHugh N. , James I. , Maddison P. Clinical significance of antibodies to 68 kDa U1RNP polypeptide in connective tissue disease. J Rheumatol 1990 ; 17: 1320-1328.

Mairesse N. , Kahn MF , Appelboom T. Antibodies to the constitutive 73-kDa heat shock protein: a new marker of mixed connective tissue disease? Am J Med 1993; 95: 595-600.

Hammenkorp R. et al. More evidence of distinctive features of mixed connective tissue disease. Scan J Rheumatol 1993; 22: 63-68.

Sharp GC Diagnostic criteria for classification of MCTD. In: Kasukawa R , Sharp GC (eds). Mixed Connective Tissue Disease and Antinuclear Antibodies . Elsevier: Amsterdam, 1987, pp 23-32.

Kasukawa R. et al. Preliminary diagnostic criteria for classification of mixed connective tissue. In: Kasukawa R , Sharp GC (eds). Mixed Connective Tissue Disease and Antinuclear Antibodies. Elsevier: Amsterdam, 1987, pp 41-47.

Alarcón Segovia D. , Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R , Sharp GC (eds). Mixed Connective Tissue Disease and Antinuclear Antibodies. Elsevier: Amsterdam, 1987, pp 33-40.

Doria A. et al. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992; 19: 259-264.

Alarcón-Segovia D. , Cardiel MH Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J. Rheumatol 1989; 16: 328-334.

Alarcón Segovia D. Mixed connective tissue disease. A decade of growing pains. J Rheumatol 1981; 8: 535-540 (editorial).